DVT Screening Devices Market
Request Sample Report
DVT Screening Devices Market Size and Growth
The DVT screening devices market is experiencing significant growth, driven by rising venous thromboembolism prevalence and technological advancements. In 2023, the market size is estimated at approximately $1.5 billion, with projections to reach $2.5 billion by 2030, highlighting increasing demand for effective diagnostic solutions across healthcare settings. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ F. Hoffmann-La Roche Ltd.
◍ Generex Biotechnology Lorporation
◍ Laboratorios Farmaceuticos Rovi, S.A.
◍ Pharmathen Pharmaceuticals S.A.
◍ Bristol-Myers Squibb Company
◍ 3SBio Inc.
◍ Dupont Pharm Co
◍ Wockhardt Ltd
◍ Bayer AG
◍ Pfizer Inc.
The DVT Screening Devices Market features companies like Roche, Bayer, and Pfizer, which enhance growth through innovative diagnostics and treatment solutions. They collaborate on research, promote awareness, and invest in advanced technologies. Some revenue figures include:
- Bayer AG: €43 billion
- Roche: CHF 63 billion
- Pfizer: $81 billion. Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Research Centre
Others
Request Sample Report
By Product
Imaging Modalities
Intravasular Ultrasound
Others
Market Growth
Request Sample Report
$ X Billion USD
